Correlation Between Utah Medical and Harvard Bioscience

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Utah Medical and Harvard Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Utah Medical and Harvard Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Utah Medical Products and Harvard Bioscience, you can compare the effects of market volatilities on Utah Medical and Harvard Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Utah Medical with a short position of Harvard Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Utah Medical and Harvard Bioscience.

Diversification Opportunities for Utah Medical and Harvard Bioscience

0.53
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Utah and Harvard is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Utah Medical Products and Harvard Bioscience in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Harvard Bioscience and Utah Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Utah Medical Products are associated (or correlated) with Harvard Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Harvard Bioscience has no effect on the direction of Utah Medical i.e., Utah Medical and Harvard Bioscience go up and down completely randomly.

Pair Corralation between Utah Medical and Harvard Bioscience

Given the investment horizon of 90 days Utah Medical Products is expected to generate 0.22 times more return on investment than Harvard Bioscience. However, Utah Medical Products is 4.52 times less risky than Harvard Bioscience. It trades about 0.07 of its potential returns per unit of risk. Harvard Bioscience is currently generating about -0.03 per unit of risk. If you would invest  6,409  in Utah Medical Products on September 2, 2024 and sell it today you would earn a total of  116.00  from holding Utah Medical Products or generate 1.81% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Utah Medical Products  vs.  Harvard Bioscience

 Performance 
       Timeline  
Utah Medical Products 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Utah Medical Products has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, Utah Medical is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
Harvard Bioscience 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Harvard Bioscience has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's forward indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Utah Medical and Harvard Bioscience Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Utah Medical and Harvard Bioscience

The main advantage of trading using opposite Utah Medical and Harvard Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Utah Medical position performs unexpectedly, Harvard Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Harvard Bioscience will offset losses from the drop in Harvard Bioscience's long position.
The idea behind Utah Medical Products and Harvard Bioscience pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments